中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury

文献类型:期刊论文

作者Yang, Cheng2,5; Xu, Zhongliang4; Zhao, Zitong2,5; Li, Long2,5; Zhao, Tian2,5; Peng, Dian4; Xu, Ming2,5; Rong, Ruiming1,2,5; Long, Ya-Qiu4; Zhu, Tongyu2,3,5
刊名BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
出版日期2014-11
卷号1842期号:11页码:2306-2317
关键词Cyclic helix B peptide Metabolic stability Kidney ischemia reperfusion injury Autophagy Apoptosis Inflammation
ISSN号0925-4439
DOI10.1016/j.bbadis.2014.09.001
文献子类Article
英文摘要Helix B surface peptide (HBSP), derived from erythropoietin, displays powerful tissue protection during kidney ischemia reperfusion (IR) injury without erythropoietic side effects. We employed cyclization strategy for the first time, and synthesized thioether-cyclized helix B peptide (CHBP) to improve metabolic stability and renoprotective effect. LC-MS/MS analysis was adopted to examine the stability of CHBP in vitro and in vivo. The renoprotective effect of CHBP in terms of renal function, apoptosis, inflammation, extracellular matrix deposition, and histological injury was also detected in vivo and in vitro. Antibody array and western blot were performed to analyze the signal pathway of involvement by CHBP in the IR model and renal tubular epithelial cells. In this study, thioether-cyclized peptide was significantly stable in vivo and in vitro. One dose of 8 nmol/kg CHBP administered intraperitoneally at the onset of reperfusion improved renal protection compared with three doses of 8 nmol/kg linear HBSP in a 48 h murine IR model. In a one-week model, the one dose CHBP-treated group exhibited remarkably improved renal function over the IR group, and attenuated kidney injury, including reduced inflammation and apoptosis. Interestingly, we found that the phosphorylation of autophagy protein mTORC1 was dramatically reduced upon CHBP treatment. We also demonstrated that CHBP induced autophagy via inhibition of mTORC1 and activation of mTORC2, leading to renoprotective effects on IR. Our results indicate that the novel metabolically stable CHBP is a promising therapeutic medicine for kidney IR injury treatment. (C) 2014 Elsevier B.V. All rights reserved.
WOS关键词RENAL ISCHEMIA/REPERFUSION INJURY ; TERTIARY STRUCTURE ; GRB2-SH2 DOMAIN ; CELL-DEATH ; AUTOPHAGY ; ERYTHROPOIETIN ; APOPTOSIS ; RECEPTOR ; PROTECTS ; PATHWAY
资助项目National Natural Science Foundation of China[81270832] ; National Natural Science Foundation of China[81270833] ; National Natural Science Foundation of China[81021062] ; National Natural Science Foundation of China[81370852] ; National Natural Science Foundation of China[81123004] ; National Natural Science Foundation of China[81400752] ; National Natural Science Foundation of China[21302201] ; Science and Technology Commission of Shanghai Municipality[12ZR1405500] ; Science and Technology Commission of Shanghai Municipality[13ZR1447700]
WOS研究方向Biochemistry & Molecular Biology ; Biophysics ; Cell Biology
语种英语
WOS记录号WOS:000343844800026
出版者ELSEVIER SCIENCE BV
源URL[http://119.78.100.183/handle/2S10ELR8/276857]  
专题药物化学研究室
通讯作者Rong, Ruiming
作者单位1.Fudan Univ, Zhongshan Hosp, Dept Transfus, Shanghai 200433, Peoples R China;
2.Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China;
3.Fudan Univ, Zhongshan Hosp, Qingpu Branch, Shanghai 200032, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China;
5.Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China;
推荐引用方式
GB/T 7714
Yang, Cheng,Xu, Zhongliang,Zhao, Zitong,et al. A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,2014,1842(11):2306-2317.
APA Yang, Cheng.,Xu, Zhongliang.,Zhao, Zitong.,Li, Long.,Zhao, Tian.,...&Zhu, Tongyu.(2014).A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,1842(11),2306-2317.
MLA Yang, Cheng,et al."A novel proteolysis-resistant cyclic helix B peptide ameliorates kidney ischemia reperfusion injury".BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1842.11(2014):2306-2317.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。